Cargando…
Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells
SH-SY5Y cells exposed to 1-methyl-4-phenylpyridinium (MPP(+)) develop mitochondrial dysfunction and other cellular responses similar to those that occur in the dopaminergic neurons of patients with Parkinson's disease (PD). It has been shown in animal models of PD that neuronal death can be pre...
Autores principales: | Chanthammachat, Pitak, Dharmasaroja, Permphan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806136/ https://www.ncbi.nlm.nih.gov/pubmed/31645842 http://dx.doi.org/10.17179/excli2019-1703 |
Ejemplares similares
-
Evaluation of the Combination of Metformin and Rapamycin in an MPP(+)-Treated SH-SY5Y Model of Parkinson's Disease
por: Norradee, Chureerat, et al.
Publicado: (2023) -
Neuroprotective Effects of Alpha-Mangostin on MPP(+)-Induced Apoptotic Cell Death in Neuroblastoma SH-SY5Y Cells
por: Janhom, Prachya, et al.
Publicado: (2015) -
Differential Expression of Tyrosine Hydroxylase Protein and Apoptosis-Related Genes in Differentiated and Undifferentiated SH-SY5Y Neuroblastoma Cells Treated with MPP(+)
por: Khwanraj, Kawinthra, et al.
Publicado: (2015) -
Carnitine Protects against MPP(+)-Induced Neurotoxicity and Inflammation by Promoting Primary Ciliogenesis in SH-SY5Y Cells
por: Bae, Ji-Eun, et al.
Publicado: (2022) -
eEF1A2 siRNA Suppresses MPP(+)-Induced Activation of Akt and mTOR and Potentiates Caspase-3 Activation in a Parkinson's Disease Model
por: Khwanraj, Kawinthra, et al.
Publicado: (2023)